Levity vs Ivim Health 2026: Pricing & Support

Levity vs Ivim Health 2026: Pricing & Support. Levity or Ivim Health for GLP-1 weight loss? We compared pricing, medications, clinical support, and real reviews to find the better option. Levity and Ivim Health are two cash-pay telehealth platforms competing for GLP-1 weight loss patients, and they take meaningfully different approaches to pricing, clinical care, and the overall patient experience. This comparison breaks down every difference that matters so you can pick the right fit. Levity Overview Levity is a GLP-1 weight loss telehealth platform launched in 2023 and backed by ZipHealth, an online pharmacy that has been operating since 2019. Levity's positioning is a simple, fully online experience: a licensed provider reviews your intake within 24–48 hours, communication happens through a secure patient portal, and medication ships monthly directly to your door. Video calls aren't required unless your state's telehealth laws mandate one. Levity prescribes brand-name Wegovy, Ozempic, and Mounjaro at transparent published pricing ($1,149–$1,599/month), plus compounded semaglutide at $175–$225/month. First-month pricing drops to $129 with the WELCOME promo code. Trustpilot currently rates Levity 4.1 / 5 based on active customer reviews, with most positive feedback centered on the simple onboarding experience and reliable shipping from ZipHealth's pharmacy. Ivim Health Overview Ivim Health has built its brand around individualized care. The platform employs 92 licensed providers who offer unlimited 1:1 virtual visits and adjust your GLP-1 dose weekly based on your progress, tolerance, and side effects. This isn't a one-size-fits-all protocol — your prescriber actively manages your treatment week by week. Ivim has been featured in the New York Times, Forbes, TIME, and CNN, and is positioned as one of the more clinically engaged telehealth GLP-1 platforms. Ivim offers both compounded GLP-1 peptides (semaglutide starting at $75/month, tirzepatide starting at $149/month) and brand-name options (Wegovy, Zepbound, Ozempic, Mounjaro) at retail pricing. The platform charges a separate $74.99/month program fee that covers provider access, the tracking app, nutrition coaching, and wellness masterclasses — bringing the total cost for compounded semaglutide to roughly $150/month and compounded tirzepatide to $224/month. Pricing Breakdown Levity's pricing is transparent and bundled: compounded semaglutide sits at $175–$225/month with medication, provider review, and shipping included. For brand-name Wegovy, Ozempic, or Mounjaro, Levity publishes monthly pricing in the $1,149–$1,599 range — which is useful if you know you want the brand-name product and want to price it upfront. First-month pricing drops to $129 with the WELCOME promo code, giving new patients $50 off. Ivim Health's pricing is structured differently: medication cost and program fee are separated. Compounded semaglutide is $75/month plus a $74.99/month program fee, putting the total at approximately $150/month — meaningfully below Levity's compounded pricing. Compounded tirzepatide totals roughly $224/month on Ivim versus Levity's brand-name-Mounjaro-only option at $1,149+. For patients focused on the lowest effective cost on compounded GLP-1s, Ivim is clearly cheaper. Clinical Support Compared This is where Ivim Health differentiates itself most clearly. The platform offers unlimited 1:1 virtual visits with 92 licensed providers and weekly dose adjustments based on your individual response. Most GLP-1 telehealth platforms follow a standardized titration schedule — increase the dose every 4 weeks regardless of how you're doing. Ivim's approach lets your provider fine-tune your dose every week based on weight loss trajectory, side effects, and tolerance. Levity provides clinical support through its secure patient portal. Providers review your initial intake within 24–48 hours, write prescriptions, and answer questions via messaging — but there are no default video calls and no weekly individualized adjustments. The titration schedule follows standard GLP-1 protocols. If you want a low-touch, fully asynchronous experience, Levity's model is fine. If you want hands-on, clinician-directed optimization with weekly check-ins, Ivim has the clear advantage. Medications Available Both platforms offer compounded semaglutide and brand-name GLP-1 medications, but the catalog differs in meaningful ways. Levity focuses on brand-name Wegovy, Ozempic, and Mounjaro alongside compounded semaglutide — a clean, focused menu. Ivim Health offers compounded semaglutide and compounded tirzepatide, plus brand-name Wegovy, Zepbound, Ozempic, and Mounjaro at retail pricing. The practical difference is compounded tirzepatide. Ivim offers it starting at $149/month; Levity does not offer compounded tirzepatide and directs patients who want tirzepatide to brand-name Mounjaro at $1,199+/month. For cost-conscious patients who specifically want tirzepatide (the active ingredient in Zepbound and Mounjaro), Ivim is the only option between the two platforms that can deliver it affordably. Onboarding and Shipping Levity's onboarding is deliberately simple: complete an online intake, wait 24–48 hours for provider review, and receive your monthly medication shipment. Blood work is not required unless your medical history flags diabetes, prediabetes, or conditions that could complicate GLP-1 treatment. Communication stays in the patient portal throughout the program, with no requirement to schedule video calls. Ivim Health's onboarding includes a comprehensive health questionnaire followed by a 1:1 virtual consultation with a licensed provider who develops your personalized treatment plan. Medication ships within 3–5 business days of approval — notably faster than most competitors. The initial consultation is thorough rather than rushed, consistent with Ivim's emphasis on individualized care. Beyond Weight Loss Levity is narrowly focused on GLP-1 weight loss. The platform doesn't offer hormone therapy, testosterone, or other telehealth services — if you want multiple health concerns managed in one place, Levity isn't built for that. Ivim Health offers a broader menu for women's health: hormone replacement therapy (starting at $199/month with a 4-month minimum), physician-formulated supplements, nutrition coaching, and wellness masterclasses alongside weight management. For patients who prefer a single-purpose platform for weight loss and nothing else, Levity's focus can actually be an advantage — less clutter, faster onboarding, clearer pricing. For patients who want GLP-1s as part of a broader health protocol, Ivim's additional services reduce the need to stack multiple telehealth subscriptions. The Verdict Both Levity and Ivim Health are legitimate telehealth platforms with licensed providers and real clinical oversight. Levity's strengths are genuine: simple async experience, transparent brand-name pricing, a 4.1 Trustpilot rating, and the backing of ZipHealth's established pharmacy. It's a strong pick if you want the lowest-friction way to get on brand-name Wegovy, Ozempic, or Mounjaro without scheduling video calls. But for GLP-1 weight loss on compounded medications specifically, Ivim Health is the stronger pick. The combination of lower effective pricing (~$150/month for compounded semaglutide all-in), 92 licensed providers with unlimited 1:1 virtual visits, weekly individualized dose adjustments, and both compounded semaglutide and tirzepatide options gives it clinical and cost advantages that Levity can't match on compounded pricing. If your primary goal is affordable compounded GLP-1 weight loss with personalized medical attention, Ivim delivers more for your money. PeptideStack page context: visitors can use the header navigation to reach the product catalog, blog, calculators, supplier pages, discount-code pages, contact page, legal policies, shipping policy, refund policy, privacy policy, terms, and research disclaimer. The site is organized around research peptide education, supplier transparency, product comparison, vendor review content, discount-code tracking, and calculator tools for reconstitution or unit conversion research planning. PeptideStack separates research-use-only peptide information from FDA-approved medication and licensed telehealth pathways. Research peptide pages are informational and are not medical advice, prescription guidance, dosing instructions, treatment recommendations, or instructions for human consumption. Many pages include affiliate disclosures because PeptideStack may earn a commission when visitors click external supplier or telehealth links. That commission does not change the price paid by visitors and does not mean PeptideStack manufactures, sells, distributes, compounds, or ships peptides or medications. Supplier and product pages should be evaluated for third-party testing, batch-specific certificates of analysis, named laboratory verification, transparent pricing, realistic delivery expectations, payment security, refund policies, support quality, and consistent research-use-only labeling. Blog pages connect related guides, comparison articles, FDA approval status explainers, safety context, legality resources, product pages, vendor reviews, and calculator tools so visitors can keep researching without relying on a single supplier claim. Calculator pages are educational tools for laboratory planning and should be cross-checked against professional protocols, institutional requirements, and applicable laws. Legal and disclaimer pages explain the boundaries of PeptideStack content and the responsibility of visitors who evaluate third-party vendors. The rendered interface may add interactive details such as mobile navigation labels, product tabs, share buttons, related article cards, disclosure boxes, call-to-action buttons, vendor selectors, copy-code controls, email-code forms, footer navigation, and status labels. The static HTML fallback includes this context so the same page purpose is understandable before the JavaScript application finishes loading. Visitors should treat PeptideStack as a research and comparison starting point. Final supplier evaluation should include direct review of the external vendor website, current product availability, checkout terms, applicable laws, institutional requirements, and any third-party laboratory documentation available for the exact product or batch being considered. Footer resources repeat important sitewide context: PeptideStack is independent, affiliate-supported, research-focused, and not a pharmacy or manufacturer. Pages may include links to the iOS app, calculators, blog hubs, product hubs, supplier comparisons, support contact, and policy documents. This repeated context is intentionally available in the raw HTML for crawlers that inspect a page before executing the React bundle. Raw HTML also includes page summaries for mobile crawlers using JavaScript rendering, desktop crawlers comparing source to rendered output, accessibility tools, and no-script visitors. The fallback is replaced by the React app in normal browsers but keeps the source document aligned with the visible page topic. This fallback keeps source HTML and rendered HTML closer for crawl diagnostics and SEO audits across crawled pages, routes, reports, and recrawls.